Company Name:

MGC Pharmaceuticals Ltd. is an Australian Company publicly listed on the ASX (ASX:MXC) founded in early 2015 by leading Israeli medical cannabis industry executives. The goal was establishing a global cannabinoid (CBD) and medical cannabis business utilizing their intellectual property, expertise and contacts, with a focus on the CBD market in Europe and Australia. MGC is operates globally with an agenda of adding value to the whole product chain, from growing and breeding unique strains to developing medicine delivery systems. With the Medical Cannabis industry, and particularly the CBD subsection of this industry booming globally, now is a time where making correct choices in partnerships and associations becomes most crucial.

Contact Information